Does A Technical Metric Suggest That Cytokinetics Inc (CYTK) Stock Is Ready To Rise?
UBS raised the price target for the Cytokinetics Inc (NASDAQ:CYTK) stock from “a Buy” to “a Neutral”. The rating was released on January 24, 2024, according to finviz. We previously noted in another research note published on January 05, 2024 by Morgan Stanley that downgraded the stock from an Overweight to an Equal-weight with a […]
Recent trade makes Cytokinetics Inc (CYTK) Stock an appealing buy
UBS raised the price target for the Cytokinetics Inc (NASDAQ:CYTK) stock from “a Buy” to “a Neutral”. The rating was released on January 24, 2024, according to finviz. We previously noted in another research note published on January 05, 2024 by Morgan Stanley that downgraded the stock from an Overweight to an Equal-weight with a […]
Cytokinetics Inc (NASDAQ:CYTK) stock Reported Profit Margin of -6988.63 percent in Last Year: Is Defensible?
UBS raised the price target for the Cytokinetics Inc (NASDAQ:CYTK) stock from “a Buy” to “a Neutral”. The rating was released on January 24, 2024, according to finviz. We previously noted in another research note published on January 05, 2024 by Morgan Stanley that downgraded the stock from an Overweight to an Equal-weight with a […]
In the current cycle, Cytokinetics Inc (CYTK) Stock is showing signs of growth
UBS raised the price target for the Cytokinetics Inc (NASDAQ:CYTK) stock from “a Buy” to “a Neutral”. The rating was released on January 24, 2024, according to finviz. We previously noted in another research note published on January 05, 2024 by Morgan Stanley that downgraded the stock from an Overweight to an Equal-weight with a […]
Getting Ready for the Bounce: Cytokinetics Inc (CYTK) Stock
UBS raised the price target for the Cytokinetics Inc (NASDAQ:CYTK) stock from “a Buy” to “a Neutral”. The rating was released on January 24, 2024, according to finviz. We previously noted in another research note published on January 05, 2024 by Morgan Stanley that downgraded the stock from an Overweight to an Equal-weight with a […]
Cytokinetics Inc (NASDAQ:CYTK) Stock Price Settled at $67.42: What’s Resulting?
UBS raised the price target for the Cytokinetics Inc (NASDAQ:CYTK) stock from “a Buy” to “a Neutral”. The rating was released on January 24, 2024, according to finviz. We previously noted in another research note published on January 05, 2024 by Morgan Stanley that downgraded the stock from an Overweight to an Equal-weight with a […]
Stay away from Cytokinetics Inc (CYTK) Stock or get into it
UBS raised the price target for the Cytokinetics Inc (NASDAQ:CYTK) stock from “a Buy” to “a Neutral”. The rating was released on January 24, 2024, according to finviz. We previously noted in another research note published on January 05, 2024 by Morgan Stanley that downgraded the stock from an Overweight to an Equal-weight with a […]
Cytokinetics Inc (NASDAQ:CYTK) Stock lower -21.92% in This Year: What’s Happened?
UBS raised the price target for the Cytokinetics Inc (NASDAQ:CYTK) stock from “a Buy” to “a Neutral”. The rating was released on January 24, 2024, according to finviz. We previously noted in another research note published on January 05, 2024 by Morgan Stanley that downgraded the stock from an Overweight to an Equal-weight with a […]
